发明名称 ORAL DRUG DELIVERY FORMULATIONS
摘要 <p>In an aspect, a formulation is provided that comprises at least one active substance and at least one coat comprising Eudragit E (dimethylaminoethyl methacrylate copolymer), wherein the formulation is free of any active substance external to the coat. The formulation is effective in preventing significant dose dumping in alcoholic/non-alcoholic beverage(s). In another aspect, a formulation is provided that comprises a loading dose having at least one active substance, wherein the release of the at least one active substance shows a Point Of Divergence (POD), in a dissolution profile, with the loading dose representing a point in a timeline where the history of the dissolution or release rate changes from an onset of action to another set of points in the timeline represented by a controlled release. The formulation may be used for releasing up to about 55% of a total dose as a loading dose in order to manage pain.</p>
申请公布号 CA2888278(A1) 申请公布日期 2014.04.24
申请号 CA20132888278 申请日期 2013.06.28
申请人 ODIDI, ISA 发明人 ODIDI, ISA
分类号 A61K9/32;A61K9/22;A61K31/485;A61K47/30;A61P25/04 主分类号 A61K9/32
代理机构 代理人
主权项
地址